GlassScriptPhysician profile
Rebecca E Walding
NPI 1215125216
$1,448.14
in general payments reported to CMS, 2019-2025
17 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family Health provider received nationally (typical 2025 total: $209).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $506 · 2022: $192 · 2023: $195 · 2024: $209 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $394.63 | 2021-2025 | |
| Alkermes, INC. | $195.92 | 2021-2025 | Lybalvi, Aristada |
| Amgen INC. | $158.70 | 2025 | Evenity, Krystexxa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.86 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $108.84 | 2022-2023 | Spravato |
| Neurocrine Biosciences, INC. | $74.98 | 2022-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $62.92 | 2023-2024 | Fanapt, Hetlioz |
| Jazz Pharmaceuticals INC. | $53.41 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $46.48 | 2022-2025 | Rexulti |
| Insulet Corporation | $45.48 | 2025 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $41.28 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.99 | 2025 | Cobenfy |
| Biohaven Pharmaceuticals, INC. | $25.78 | 2021 | |
| Supernus Pharmaceuticals, INC. | $22.68 | 2021 | |
| Indivior INC. | $17.49 | 2024 | Perseris |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $15.98 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.72 | 2024 | Uzedy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Walding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.